Adenoviral transfer of antisenses or ribozyme to O6-methylguanine-DNA methyltransferase mRNA in brain-tumor model resistant to chloroethyl-nitrosourea

Anticancer Research

Volumn 22, Issue 4, 2002, Pages 2029-2036

  Manome, Yoshinobu ^a   Yoshinaga, Hisao ^a   Watanabe, Michiko ^a   Ohno, Tsuneya ^a  

^a Department of Microbiology ^*  (Japan)

Author keywords

Antisense; Brain tumor; Drug resistance; Nitrosourea; Ribozyme

Indexed keywords

ADENOVIRUS VECTOR; CHLOROETHYLNITROSOUREA; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE; RIBOZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; EXPRESSION VECTOR; HUMAN; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0036339660     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nitrosourea chemotherapy for primary malignant gliomas
2. Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors
3. Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents
4. Development of a syngenic brain-tumor model resistant to chloroethyl-nitrosourea using a methylguanine DNA methyl-transferase cDNA
5. Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea
6. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts
7. Adenovirus-based expression vectors and recombinant vaccines
8. cDNA cloning and chromosomal assignment of the human O6-methylguanine-DNA methyltransferase. cDNA expression in Escherichia coli and gene expression in human cells
9. Ribozyme-mediated modulation of human O6-methylguanine-DNA methyltransferase expression
10. Enhancer sequences of the DF 3 gene regulate expression of the herpes simplex virus thymidine kinase gene and confer sensitivity of human breast cancer cells to ganciclovir
11. An improved rat brain tumor model
12. Gene therapy for malignant gliomas using replication incompetent retroviral and adenoviral vectors encoding the cytochrome P450 2B1 gene together with cyclophosphamide
13. Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas
14. Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferase
15. Modulation of O6-methylguanine-DNA methyltransferase-mediated 1-(4-amino-2-methyl-5-pyrimidinyl) met hyl-3-(2-chloroethyl)-3-nitro-sourea resistance by O6-benzylguanine in vitro and in vivo
16. Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea
17. Prolonged inhibition of O(6)-methylguanine DNA methyltransferase in human tumor cells by O(6)-benzylguanine in vitro and in vivo
18. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2′-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity
19. Enhancing effect of O6-alkylguanine derivatives on chloroethylnitrosourea cytotoxicity toward tumor cells
20. Effects of streptozotocin/bis-chloroethylnitrosourea combination therapy on O6-methylguanine DNA methyltransferase activity and mRNA levels in HT- 29 cells in vitro
21. Substrate specificity of human O6-methylguanine-DNA methyl-transferase for O6-benzylguanine derivatives in oligodeoxy-nucleotides
22. Ribozyme and free alkylated base: A dual approach for sensitizing Mex+ cells to the alkylating antineoplastic drug
23. Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation
24. Depletion of O6-methylguanine-DNA methyltransferase and potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea antitumor activity by O6-benzylguanine in vitro
25. Modulation of O6-methylguanine-DNA methyltransferase-mediated 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea resistance by antisense RNA
26. Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/Mex+ transfected cells to mitozolomide
27. The chemistry of self-splicing RNA and RNA enzymes
28. Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O6-methylguanine DNA methyltransferase mRNA
29. The role of mRNA stability and transcription in O6-methylguanine DNA methyltransferase (MGMT) expression in Mer+ human tumor cells
30. The sensitization of cells treated with O6-methylguanine to alkylation damage is affected by the number of O6-methylguanine-DNA methyltransferase molecules escaped from inactivation